|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMST05050007
|
Ximaosteroid D
|
3beta-(2'-O-acetyl-alpha-fucopyranosyloxy)-pregna-5,20-diene
|
|
C29H44O6
|
488.313790
|
|
LMST05050008
|
Evasterioside C
|
3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-24-nor-cholest-22E-en-26-yl sulfate
|
|
C31H52O12S
|
648.317952
|
|
LMST05050008
|
Evasterioside C
|
3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-24-nor-cholest-22E-en-26-yl sulfate
|
|
C31H52O12S
|
648.317952
|
|
LMST05050009
|
Evasterioside D
|
24S-(beta-D-glucopyranosyloxy)-5-alpha-cholestan-3beta,6alpha,8,15beta-tetrol
|
|
C33H58O10
|
614.403000
|
|
LMST05050010
|
Evasterioside E
|
3beta,24S-di-(beta-D-xylopyranosyloxy)-5-alpha-cholestan-6beta,8,15alpha-triol
|
|
C37H64O13
|
716.434695
|
|
LMST05050011
|
Asteriidoside L
|
3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-campest-22E-en-28-yl sulfate
|
|
C33H56O12S
|
676.349252
|
|
LMST05050011
|
Asteriidoside L
|
3beta-(beta-D-xylopyranosyloxy)-6beta,8beta,15alpha-trihydroxy-campest-22E-en-28-yl sulfate
|
|
C33H56O12S
|
676.349252
|
|
LMST05050012
|
Evasterioside A
|
(25S)-3beta-(beta-D-xylopyranosyloxy)-6beta,8,15alpha-trihydroxy-5alpha-campest-22E-en-26-yl sulfate
|
|
C33H56O12S
|
676.349252
|
|
LMST05050012
|
Evasterioside A
|
(25S)-3beta-(beta-D-xylopyranosyloxy)-6beta,8,15alpha-trihydroxy-5alpha-campest-22E-en-26-yl sulfate
|
|
C33H56O12S
|
676.349252
|
|
LMST05050013
|
Evasterioside B
|
24-(beta-D-xylopyranosyloxy)-6beta,8,15alpha-trihydroxy-5alpha-cholest-22E-en-3-yl sulfate
|
|
C32H54O12S
|
662.333602
|
|
LMST05050013
|
Evasterioside B
|
24-(beta-D-xylopyranosyloxy)-6beta,8,15alpha-trihydroxy-5alpha-cholest-22E-en-3-yl sulfate
|
|
C32H54O12S
|
662.333602
|
|
LMST05050014
|
Kurilensoside E
|
(25S)-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-5alpha-cholestan-4beta,8,15alpha,16beta,26-pentol
|
|
C33H58O10
|
614.403000
|
|
LMST05050015
|
Kurilensoside F
|
(25S)-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-cholestan-4beta,5alpha,,8,15alpha,16beta,26-hexol
|
|
C33H58O11
|
630.397915
|
|
LMST05050016
|
Kurilensoside G
|
(25S)-3beta-(beta-D-xylopyranosyloxy)-cholest-5-en-4beta,5alpha,8,15alpha,16beta,26-pentol
|
|
C32H54O10
|
598.371700
|
|
LMST05050017
|
Kurilensoside H
|
(25S)-3beta-(beta-D-xylopyranosyloxy)-4beta,5beta-epoxycholestan-6beta,8,15alpha,16beta,26-pentol
|
|
C32H54O11
|
614.366615
|
|
LMST05050018
|
Echinasteroside C 15-O-sulfate
|
(25S)-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-6beta,8,16beta,26-tetrahydroxycholest-5-en-15alpha-yl sulfate
|
|
C33H56O13S
|
692.344167
|
|
LMST05050018
|
Echinasteroside C 15-O-sulfate
|
(25S)-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-6beta,8,16beta,26-tetrahydroxycholest-5-en-15alpha-yl sulfate
|
|
C33H56O13S
|
692.344167
|
|
LMST05050019
|
Kurilensoside I
|
3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-24R-[2-O-methyl-beta-D-xylopyranosyl-(1-5)-alpha-L-arabinofuranosyloxy]-5alpha-cholest-22E-en-4beta,6alpha,7alpha,8,15beta-pentol
|
|
C44H74O19
|
906.482435
|
|
LMST05050020
|
Kurilensoside J
|
3beta-(2-O-3beta-(2-O-methyl-beta-D-xylopyranosyloxy)-24S-(alpha-L-arabinofuranosyloxy)-5alpha-cholestan-4beta,6beta,15alpha-triol-beta-D-xylopyranosyloxy)-24R-[2-O-methyl-beta-D-xylopyranosyl-(1-5)-alpha-L-arabinofuranosyloxy]-5alpha-cholest-22E-en-4beta,6alpha,7alpha,8,15beta-pentol
|
|
C37H64O14
|
732.429610
|
|
LMST05050021
|
Anthenoside A
|
16alpha-(4-O-methyl-2-acetamido-2-deoxy-beta-D-glucopyranosyloxy)-5alpha-stigmast-8(14)-en-3alpha,6beta,7beta-triol
|
|
C38H65NO9
|
679.465934
|
|
LMST05050022
|
Novaeguinoside A
|
6alpha-(4-O-sulfonato-beta-D-quinovopyranosyloxy)-5alpha-cholest-9(11)-en-3beta,24-diyl disulfate
|
|
C33H56O16S3
|
804.273056
|
|
LMST05050022
|
Novaeguinoside A
|
6alpha-(4-O-sulfonato-beta-D-quinovopyranosyloxy)-5alpha-cholest-9(11)-en-3beta,24-diyl disulfate
|
|
C33H56O16S3
|
804.273056
|
|
LMST05050023
|
Novaeguinoside B
|
(25R)-6alpha-(4-O-sulfonato-beta-D-quinovopyranosyloxy)-3beta-sulfoxy-5alpha-campest-9(11),22E-dien-26-oyl taurine
|
|
C36H59NO17S3
|
873.294520
|
|
LMST05050023
|
Novaeguinoside B
|
(25R)-6alpha-(4-O-sulfonato-beta-D-quinovopyranosyloxy)-3beta-sulfoxy-5alpha-campest-9(11),22E-dien-26-oyl taurine
|
|
C36H59NO17S3
|
873.294520
|
|
LMST05050023
|
Novaeguinoside B
|
(25R)-6alpha-(4-O-sulfonato-beta-D-quinovopyranosyloxy)-3beta-sulfoxy-5alpha-campest-9(11),22E-dien-26-oyl taurine
|
|
C36H59NO17S3
|
873.294520
|
|
LMST05050024
|
Squalamine
|
3beta-N-1-(N-[3-(4-aminobutyl)]- 1,3-diaminopropane)-7alpha,24R-dihydroxy-5alpha-cholestane 24-sulfate
|
|
C34H65N3O5S
|
627.464494
|
|
LMST05050024
|
Squalamine
|
3beta-N-1-(N-[3-(4-aminobutyl)]- 1,3-diaminopropane)-7alpha,24R-dihydroxy-5alpha-cholestane 24-sulfate
|
|
C34H65N3O5S
|
627.464494
|
|
LMST05050025
|
Dendrogenin A
|
5alpha-hydroxy-6beta-[2-(1H-imidazol-4-yl)-ethylamino]-cholestan-3beta-ol
|
|
C32H55N3O2
|
513.429427
|
|
LMST05050027
|
16,23-epoxy-5beta-cholestane triglycoside
|
(3beta,5beta,16beta,22R,23S)-22-hydroxy-16,23-epoxycholest-24-en-3-yl 6-deoxy-alpha-L-mannopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->2)-beta-D-glucopyranoside
|
|
C45H74O17
|
886.492605
|
|
LMST05050028
|
17-beta-estradiol glucuronide
|
3-hydroxyestra-1,3,5(10)-trien-17beta-yl beta-D-glucopyranosiduronic acid
|
ST 18:3;O2;GlcA
|
C24H32O8
|
448.209720
|
|
LMST05050029
|
Cholesteryl-alpha-D-glucoside
|
Cholest-5-en-3beta-yl alpha-D-glucopyranoside
|
ST 27:1;O;Hex
|
C33H56O6
|
548.407690
|
|
LMST05050030
|
14:0-Glc-Cholesterol
|
Cholesteryl-6-O-tetradecanoyl-alpha-D-glucopyranoside
|
|
C47H82O7
|
758.606055
|
|
LMST05050032
|
Hesperuside A
|
7-O-(6-O-methyl-beta-D-galactofuranosyl)-16-O-(3-O-methyl-beta-D-galactopyranosyl)-cholest-8(14),22E-dien-3alpha,6beta,7beta,16alpha-tetrol
|
|
C41H68O14
|
784.460910
|
|
LMST05050033
|
Hesperuside B
|
7-O-(6-O-methyl-beta-D-galactofuranosyl)-16-O-(3-O-methyl-beta-D-galactopyranosyl)-cholest-8(14)-en-3alpha,6beta,7beta,16alphatetrol
|
|
C41H70O14
|
786.476560
|
|
LMST05050034
|
Hesperuside C
|
7-O-(6-O-methyl-beta-D-galactofuranosyl)-16-O-(3-O-methyl-beta-D-galactopyranosyl)-24-methylene-cholest-8(14)-en-3alpha,6beta,7beta,16alphatetrol
|
|
C42H70O14
|
798.476560
|
|
LMST05050035
|
Microdiscusoside A
|
25S-3-O-(beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholesta-4,24(28)-diene-3 beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C38H62O13
|
726.419045
|
|
LMST05050036
|
Fuscaside B
|
(24S)-3,24-di-O-(beta-D-xylopyranosyl)-5alpha-cholestane-3beta,6beta,8,15alpha,24-pentol
|
|
C37H64O12
|
700.439780
|
|
LMST05050037
|
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholest-4-ene-3beta,6beta,7alpha,8,15alpha,16beta,26-heptaol
|
|
C38H64O15
|
760.424525
|
|
LMST05050038
|
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholest-4,24(28)-diene-3beta,6beta,7alpha,8,15alpha,16beta,26-heptaol
|
|
C39H64O15
|
772.424525
|
|
LMST05050039
|
Linckoside I
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-26-O-(beta-D-xylopyranosyl)-cholest-4,24(28)-diene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C39H64O14
|
756.429610
|
|
LMST05050040
|
Linckoside F
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-cholest-4,24(28)-diene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C34H56O10
|
624.387350
|
|
LMST05050041
|
Linckoside H
|
(25S)-3-O-(beta-D-xylopyranosyl)-cholest-4,24(28)-diene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C33H54O10
|
610.371700
|
|
LMST05050042
|
Linckoside G
|
(25S)-3-O-(beta-D-xylopyranosyl)-cholest-4,22E-diene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C32H52O10
|
596.356050
|
|
LMST05050043
|
Linckoside J
|
(25S)-3-O-(beta-D-xylopyranosyl)-cholest-4-ene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C32H54O10
|
598.371700
|
|
LMST05050044
|
Echinasteroside C
|
(25S)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-cholest-4-ene-3beta,6beta,8,15alpha,16beta,26-hexaol
|
|
C33H56O10
|
612.387350
|
|
LMST05050045
|
Linckoside K
|
(24R)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-28-O-(alpha-arabinofuranosyl)-ergosta-4,22E-diene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C39H64O14
|
756.429610
|
|
LMST05050046
|
Linckoside E
|
(24R)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-28-O-(alpha-arabinofuranosyl)-ergosta-4-ene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C39H66O14
|
758.445260
|
|
LMST05050047
|
Linckoside A
|
(24R)-3-O-(2-O-methyl-beta-D-xylopyranosyl)-29-O-(alpha-arabinofuranosyl)-stigmasta-4-ene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C40H68O14
|
772.460910
|
|
LMST05050048
|
Linckoside B
|
3-O-(2-O-methyl-beta-D-xylopyranosyl)-29-O-(beta-D-xylopyranosyl)-stigmasta-4-ene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C40H68O14
|
772.460910
|
|
LMST05050049
|
Linckoside C
|
3-O-(2-O-methyl-beta-D-xylopyranosyl)-29-O-(beta-D-xylopyranosyl)-28S-methyl-stigmasta-4-ene-3beta,6beta,8,15alpha,16beta,28-hexaol
|
|
C41H70O14
|
786.476560
|